The beliefs of non-psychiatric doctors about the causes, treatments, and prognosis of schizophrenia.
beliefs
causal explanations
health professionals
schizophrenia
treatments
Journal
Psychology and psychotherapy
ISSN: 2044-8341
Titre abrégé: Psychol Psychother
Pays: England
ID NLM: 101135751
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
24
05
2019
revised:
23
07
2019
pubmed:
11
9
2019
medline:
7
9
2021
entrez:
11
9
2019
Statut:
ppublish
Résumé
To examine the causal beliefs about schizophrenia of non-psychiatric doctors and whether differential belief in biogenetic vs. psychosocial causes influences doctors' views about treatments and prognosis. Three hundred and five non-psychiatric doctors working in outpatient community centres completed the 'Opinions on mental disorders Questionnaire' after reading a clinical description of people with schizophrenia. The factors most frequently reported as causes of schizophrenia were heredity (65.2%) and use of street drugs (54.1%). Seventy-five per cent of participants endorsed both one or more biological causal factors and one or more psychosocial causal factors. Of the 264 participants who expressed their opinion about the most important cause of schizophrenia, 53.8% indicated a biogenetic cause. Fifty-two per cent of respondents thought it 'completely true' that drugs are useful in schizophrenia, and 33.9% thought it 'completely true' that people with schizophrenia must take drugs all their life. Participants stating that the most important cause was biogenetic more frequently recommended a psychiatrist and less frequently a psychologist. Compared to doctors who indicated a psychosocial cause as the most important one, those who indicated a biogenetic cause were more sceptical about recovery, more confident in the usefulness of drugs, and more convinced of the need of lifelong pharmacological treatments in schizophrenia. These findings suggest the need to provide some doctors with training on the multiple, interacting causes of schizophrenia and the efficacy of the broad range of available treatments. The education of health professionals regarding stigma and its effects on clinical practice is also needed. Viewing schizophrenia as mainly due to a biological cause is associated with greater confidence in the usefulness of drugs, higher belief in the need for lifelong pharmacological treatments, and greater prognostic pessimism. Belief in a biologically oriented model of schizophrenia may lead doctors to underestimate the value of psychologists. Prognostic pessimism among doctors may negatively influence clinical decisions, the information doctors provide to their clients, and clients' own beliefs about their chances of recovery. Belief in the need for lifelong pharmacological treatments in schizophrenia may lead doctors to resist drug withdrawal in case of severe side effects.
Substances chimiques
Antipsychotic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
674-689Informations de copyright
© 2019 The British Psychological Society.
Références
Adewuya, A. O., & Ognutade, A. (2007). Doctors’ attitude towards people with mental illness in Western Nigeria. Social Psychiatry and Psychiatric Epidemiology, 42, 931-936. https://doi.org/10.1007/s00127-007-0246-4
Ahn, W., Proctor, C. C., & Flanagan, E. H. (2009). Mental health clinicians’ beliefs about the biological, psychological, and environmental bases of mental disorders. Cognitive Science, 33, 147-182. https://doi.org/10.1111/j.1551-6709.2009.01008.x
Angermeyer, M., & Matschinger, H. (2005). Causal beliefs and attitudes to people with schizophrenia. British Journal of Psychiatry, 186, 331-334. https://doi.org/10.1192/bjp.186.4.331
Bellack, A. S. (2006). Scientific and consumer models of recovery in schizophrenia: Concordance, contrasts, and implications. Schizophrenia Bulletin, 32, 432-442. https://doi.org/10.1093/schbul/sbj044
Bentall, R. (2013). Understanding psychotic symptoms: Cognitive and integrative models. In J., Read, & J., Dillon (Ed.), Models of madness: Psychological, social and biological approaches to psychosis (2th ed., pp. 220-237). London, UK: Routledge.
Bola, J. R., Kao, D., & Soydan, H. (2011). Antipsychotic medication for early episode schizophrenia (Review). Cochrane Database of Systematic Reviews, 15, CD006374. https://doi.org/10.1002/14651858.CD006374.pub2
Bola, J. R., Lehtinen, K., Cullberg, J., & Ciompi, L. (2009). Psychosocial treatment, antipsychotic postponement and low-dose medication strategies in first episode psychosis: A review of the literature. Psychosis, 1, 4-18. https://doi.org/10.1080/17522430802610008
Carter, L., Read, J., Pyle, M., & Morrison, A. P. (2017). The impact of causal explanations on outcome in people experiencing psychosis: A systematic review. Clinical Psychology and Psychotherapy, 24, 332-347. https://doi.org/10.1002/cpp.2002
Corrigan, P. W., Mittal, D., Reaves, C. M., Haynes, T. F., Han, X., Morris, S., & Sullivan, G. (2014). Mental health stigma and primary healthcare decisions. Psychiatry Research, 218, 35-38. https://doi.org/10.1016/j.psychres.2014.04.028
Corrigan, P. W., Scott, B. M., Patrick, J. M., Jennifer, D. R., & Rusch, N. (2012). Challenging the public stigma of mental illness: A meta-analysis of outcome studies. Psychiatric Services, 63, 963-973. https://doi.org/10.1176/appi.ps.201100529
Deacon, B. J. (2013). The biomedical model of mental disorder: A critical analysis of its validity, utility, and effects on psychotherapy research. Clinical Psychology Review, 33, 846-861. https://doi.org/10.1016/j.cpr.2012.09.007
Grausgruber, A., Meise, U., Katsching, H., Schöny, W., & Fleischhacker, W. W. (2007). Patterns of social distance towards people suffering from schizophrenia in Austria: A comparison between the general public, relatives and mental health staff. Acta Psychiatrica Scandinavica, 115, 310-319. https://doi.org/10.1111/j.1600-0447.2006.00882.x
Gumus, A. B. (2008). Health education needs of patients with schizophrenia and their relatives. Archives of Psychiatric Nursing, 22, 156-165. https://doi.org/10.1016/j.apnu.2007.06.015
Haddock, G., Einsner, E., Boone, C., Davies, G., Coogan, C., & Barrowclough, C. (2014). An investigation of the implementation of NICE-recommended CBT interventions for people with schizophrenia. Journal of Mental Health, 23, 162-165. https://doi.org/10.3109/09638237.2013.869571
Haslam, N. (2011). Genetic essentialism, neuroessentialism, and stigma: Commentary on Dar-Nimrod and Heine. Psychological Bulletin, 137, 819-824. https://doi.org/10.1037/a0022386
Henderson, C., Noblett, J., Parke, H., Clement, S., Caffrey, A., Gale-Grant, O., … Thornicroft, G. (2014). Mental health-related stigma in health care and mental health-care settings. Lancet Psychiatry, 1, 467-482. https://doi.org/10.1016/S2215-0366(14)00023-6
Hutton, P., Weinmann, S., Bola, J., & Read, J. (2013). Antipsychotic drugs. In J. Read & J. Dillon (Eds.), Models of madness psychological, social and biological approaches to psychosis (2nd ed., pp. 105-125). London, UK: Routledge.
IBM Corp. Released (2012). IBM SPSS statistics for Windows, version 21.0. Armonk, NY: IBM Corp.
Jorm, A. M., & Griffiths, K. M. (2008). The public's stigmatizing attitudes towards people with mental disorders: How important are biomedical conceptualizations? Acta Psychiatrica Scandinavica, 118, 315-321. https://doi.org/10.1111/j.1600-0447.2008.01251.x
Joseph, J. (2006). The missing gene: Psychiatry, heredity and the fruitless search for gene. New York, NY: Algora.
Joseph, J. (2013). “Schizophrenia” and heredity: why the emperor (still) has no genes. In J. Read & J. Dillon (Eds.), Models of madness psychological, social and biological approaches to psychosis (2nd ed., pp. 72-90). London, UK: Routledge.
Jung, E., Wiesjahn, M., Wendt, H., Bock, T., Rief, W., & Lincoln, T. M. (2016). Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication. Psychological Medicine, 46, 2179-2188. https://doi.org/10.1017/S0033291716000775
Kvaale, E. P., Haslam, N., & Gottdiener, W. H. (2013). The ‘side effects’ of medicalization: A meta-analytic review of how biogenetic explanations affect stigma. Clinical Psychology Review, 33, 782-794. https://doi.org/10.1016/j.cpr.2013.06.002
Larkings, J. S., & Brown, P. M. (2018). Do biogenetic causal beliefs reduce mental illness stigma in people with mental illness and in mental health professionals? A systematic review. International Journal of Mental Health Nursing, 27, 928-941. https://doi.org/10.1111/inm.12390
Lebowitz, M. S., & Ahn, W. K. (2014). Effects of biological explanations for mental disorders on clinicians’ empathy. Proceedings of the National Academy of Sciences of the United States of America, 11, 17786-17790. https://doi.org/10.1073/pnas.1414058111
Magliano, L., Fiorillo, A., De Rosa, C., Malangone, C., & Maj, M. (2004). Beliefs about schizophrenia in Italy: A comparative nationwide survey of the general public, mental health professionals, and patients’ relatives. The Canadian Journal of Psychiatry, 49, 322-330.
Magliano, L., Fiorillo, A., Del Vecchio, H., Malangone, C., De Rosa, C., Bachelet, C., & Maj, M. (2009). What people with schizophrenia think about the causes of their disorder. Epidemiology and Social Psychiatry, 18, 48-53. https://doi.org/10.1017/S1121189X00001457
Magliano, L., Marasco, C., Fiorillo, A., Malangone, C., Guameri, M., Maj, M., & the Working Group of the Italian National Study on Families of Persons with Schizophrenia (2002). The impact of professional and social network support on the burden of families of patients with schizophrenia in Italy. Acta Psychiatrica Scandinavica, 106, 291-298. https://doi.org/10.1034/j.1600-0447.2002.02223.x
Magliano, L., & Marassi, R. (2018). “Schizophrenia” and “psychosis” in Italian national newspapers: Do these terms convey different messages? Schizophrenia Research, 197, 611-612. https://doi.org/10.1016/j.schres.2018.02.021
Magliano, L., Read, J., Sagliocchi, A., Oliviero, N., D'Ambrosio, A., Campitiello, F., … Patalano, M. (2014). “Social dangerousness and incurability in schizophrenia”: Results of an educational intervention for medical and psychology students. Psychiatry Research, 219, 457-463. https://doi.org/10.1016/j.psychres.2014.06.002
Magliano, L., Read, J., Sagliocchi, A., Patalano, M., & Oliviero, N. (2013). Effect of diagnostic labeling and causal explanations on medical students’ views about treatments for psychosis and the need to share information with service users. Psychiatry Research, 210, 402-407. https://doi.org/10.1016/j.psychres.2013.07.022
Magliano, L., Rinaldi, A., Costanzo, R., De Leo, R., Schioppa, G., Petrillo, M., & Read, J. (2016). Improving psychology students’ attitudes toward people with schizophrenia: A quasi-randomized controlled study. American Journal of Orthopsychiatry, 86, 253-264. https://doi.org/10.1037/ort0000161
Magliano, L., Strino, A., Punzo, R., Acone, R., Affuso, G., & Read, J. (2017). Effect of the diagnostic label “schizophrenia”, actively used or passively accepted, on general practitioners’ views of the disorder. International Journal of Social Psychiatry, 63, 1-11. https://doi.org/10.1177/0020764017695353
Ministero della Salute, Agenzia Nazionale per i Servizi Sanitari Regionali (2017). Programma Nazionale Esiti, edizione 2017. Retrieved from http://www.agenas.it/images/agenas/pne/SINTESI_PNE_2017_19_DICEMBRE.pdf
Morrison, A. P. (2013). Cognitive therapy for people experiencing psychosis. In J. Read & J. Dillon (Eds.), Models of madness psychological, social and biological approaches to psychosis (2nd ed., pp. 319-335). London, UK: Routledge.
Morrison, A. P., Turkington, D., Pyle, M., Spencer, H., Brabban, A., Dunn, G., … Hutton, P. (2014). Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: A single-blind randomised controlled trial. The Lancet, 383, 1395-1403. https://doi.org/10.1016/S0140-6736(13)62246-1
Ng, R. M., Pearson, V., Chen, E. E., & Law, C. W. (2011). What does recovery from schizophrenia mean? Perceptions of medical students and trainee psychiatrists. International Journal of Social Psychiatry, 57, 248-262. https://doi.org/10.1177/0020764009354833
Pattyn, E., Verhaeghe, M., Sercu, C., & Bracke, P. (2013). Medicalizing versus psychologizing mental illness: what are the implications for help seeking and stigma? A general population study. Social Psychiatry and Psychiatric Epidemiology, 48, 1637-1645. https://doi.org/10.1007/s00127-013-0671-5
Phelan, J. C. (2005). Geneticization of deviant behavior and consequences for stigma: The case of mental illness. Journal of Health and Social Behavior, 46, 307-322. https://doi.org/10.1177/002214650504600401
Prytys, M., Garety, P. A., Jolley, S., Onwumere, J., & Craig, T. (2011). Implementing the NICE guideline for schizophrenia recommendations for psychological therapies: A qualitative analysis of the attitudes of CMHT staff. Clinical Psychology & Psychotherapy, 18, 48-59. https://doi.org/10.1002/cpp.691
Read, J., Bentall, R., & Fosse, R. (2009). Time to abandon the bio-bio-bio model of psychosis: Exploring the epigenetic and psychological mechanisms by which adverse life events lead to psychotic symptoms. Epidemiologia e Psichiatria Sociale, 18, 299-310. https://doi.org/10.1017/S1121189X00000257
Read, J., & Dillon, J. (2013). Models of madness: Psychological, social and biological approaches to psychosis (2nd ed.). London, UK: Routledge.
Read, J., Haslam, N., & Magliano, L. (2013). Prejudice, stigma and ‘schizophrenia’: the role of biogenetic ideology. In J., Read, & J., Dillon (Ed.), Models of madness: Psychological, social and biological approaches to psychosis (2th ed., pp. 157-177). London, UK: Routledge.
Read, J., Haslam, N., Sayce, L., & Davies, E. (2006). Prejudice and schizophrenia: A review of the ‘Mental illness is an illness like any other’ approach. Acta Psychiatrica Scandinavica, 114, 303-318. https://doi.org/10.1111/j.1600-0447.2006.00824.x
Read, J., Magliano, L., & Beavan, V. (2013). Public beliefs about the causes of ‘schizophrenia’: Bad things happen and can drive you crazy. In J. Read & J. Dillon (Eds.), Models of madness: Psychological, social and biological approaches to psychosis (2nd ed., pp. 143-156). London, UK: Routledge.
Read, J., & Williams, J. (2019). Positive and negative effects of antipsychotic medication: An international online survey of 832 recipients. Current Drug Safety, 14, https://doi.org/10.2174/1574886314666190301152734
Robinson, P., Turk, D., Jilka, S., & Cella, M. (2019). Measuring attitudes towards mental health using social media: Investigating stigma and trivialisation. Social Psychiatry and Psychiatric Epidemiology, 54, 51-58. https://doi.org/10.1007/s00127-018-1571-5
Rusch, N., Todd, A. R., Bodenhausen, G. V., & Corrigan, P. W. (2010). Biogenetic models of psychopathology, implicit guilt, and mental illness stigma. Psychiatry Research, 179, 328-332. https://doi.org/10.1016/j.psychres.2009.09.010
Sartorius, N., Gaebel, W., Cleveland, R. H., Stuart, H., Akiyama, T., Arboleda-Flórez, J., … Tasman, A. (2010). WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry, 9, 131-144. https://doi.org/10.1002/j.2051-5545.2010.tb00296.x
Schomerus, G., Matschinger, H., & Angermeyer, M. C. (2014). Causal beliefs of the public and social acceptance of persons with mental illness: A comparative analysis of schizophrenia, depression and alcohol dependence. Psychological Medicine, 44, 303-314. https://doi.org/10.1017/S003329171300072X
Schomerus, G., Schwahan, C., Holzinger, A., Corrigan, P. W., Grabe, H. J., Carta, M. G., & Angermeyer, M. C. (2012). Evolution of public attitudes about mental illness; A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 125, 440-452. https://doi.org/10.1111/j.1600-0447.2012.01826.x
Shefer, G., Henderson, C., Howard, L. M., Murray, J., & Thornicroft, G. (2014). Diagnostic overshadowing and other challenges involved in the diagnostic process of patients with mental illness who present in emergency departments with physical symptoms - A qualitative study. PLoS ONE, 9, Article e111682. https://doi.org/10.1371/journal.pone.0111682
Stuber, J., Meyer, I., & Link, B. (2008). Stigma, prejudice, discrimination and health. Social Sciences and Medicine, 67, 351-357. https://doi.org/10.1016/j.socscimed.2008.03.023
Thornicroft, G., Rose, D., & Kassam, A. (2007). Discrimination in health care against people with mental illness. International Review of Psychiatry, 19, 113-122. https://doi.org/10.1080/09540260701278937
Tibaldi, G., & Govers, L. (2011). Evidence-based hope for recovery from “schizophrenia”: A common objective for all stakeholders in the mental health field. Psychosis, 4, 105-114. https://doi.org/10.1080/17522439.2011.584349
Ucok, A., Soygur, H., Atakli, C., Kuscu, K., Sartorius, N., Duman, Z. C., Polat, A., & Erkoc, S. (2006). The impact of antistigma education on the attitudes of general practitioners regarding schizophrenia. Psychiatry and Clinical Neurosciences, 60, 439-443. https://doi.org/10.1111/j.1440-1819.2006.01529.x
Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015). Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: A systematic review and meta-analysis. World Psychiatry, 14, 339-347. https://doi.org/10.1002/wps.20252
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., … Bentall, R. P. (2012). Childhood adversities increase the risk of psychosis: A meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophrenia Bulletin, 38, 661-671. https://doi.org/10.1093/schbul/sbs050
Vistorte, A. O. R., Ribeiro, W. S., Jaen, D., Jorge, M. R., Evans-Lacko, S., & Mari, J. J. (2018). Stigmatizing attitudes of primary care professionals towards people with mental disorders: A systematic review. International Journal of Psychiatry in Medicine, 53, 317-338. https://doi.org/10.1177/0091217418778620
Warner, R. (2009). Recovery from schizophrenia and the recovery model. Current Opinions in Psychiatry, 22, 374-380. https://doi.org/10.1097/YCO.0b013e32832c920b
Wiesjahn, M., Jung, E., Kremser, J. D., Rief, W., & Lincoln, T. M. (2016). The potential of continuum versus biogenetic beliefs in reducing stigmatization against persons with schizophrenia: An experimental study. Journal of Behavior Therapy & Experimental Psychiatry, 50, 231-237. https://doi.org/10.1016/j.jbtep.2015.09.007